TABLE 1.
Species and strain | Serogroup | Epidemiological group | Origin | Sourcea |
---|---|---|---|---|
N. meningitidis | ||||
BF2 | B | ET-37 complex | Italy | a |
93/4286 | C | ET-37 complex | Norway | b |
NGP165 | B | ET-37 complex | Norway | b |
FAM18 | C | ET-37 complex | United States | World Wide Web |
BZ169 | B | ET-5 complex | The Netherlands | b |
H44/76 | B | ET-5 complex | Norway | b |
MC58 | B | ET-5 complex | Scotland | World Wide Web |
205900 | A | Subgroup IV-1 | Italy | b |
Z2491 | A | Subgroup IV-1 | The Gambia | World Wide Web |
BL859 | B | Lineage 3 | Italy | c |
BS845 | B | Lineage 3 | Italy | c |
BL892 | B | Lineage 3 | France | d |
BF9 | B | Italy | a | |
B1940 | B | Germany | e | |
BL947 | B | France | d | |
NGF26 | B | Norway | b | |
NGE31 | B | Norway | b | |
NGH15 | B | Norway | b | |
N. lactamica | ||||
21 | France | d | ||
411 | France | d | ||
4627 | France | d |
a, II Policlinico, Università di Napoli, Naples, Italy; b, IRIS, Chiron S.p.A, Siena, Italy; c, Istituto Superiore di Sanità, Rome, Italy; d, Institut Pasteur, Paris, France; and e, Bayerische Julius-Maximilians Universität, Würzburg, Germany.